FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2602076204> ?p ?o ?g. }

• W2602076204 abstract "Introduction . Functional dyspepsia (FD), a common upper gastrointestinal disease, is difficult to manage because of the limitations of current conventional treatments. Yukgunja-tang (YGJT) is widely used to treat FD in clinical practice in Korea, Japan, and China. However, YGJT significantly improves few symptoms of FD. In Korean medicine, FD is a well-known functional gastric disease that shows difference in the effect of herbal medicine depending on constitution or type of Korean medicine diagnosis. This study aims to investigate the efficacy of YGJT on FD patients classified by 3-dimensional facial measurement using a 3-dimensional facial shape diagnostic system (3-FSDS). Methods . A placebo-controlled, double-blind, randomized, two-center trial will be performed to evaluate the efficacy of YGJT on FD patients. Eligible subjects will be initially classified as two types by 3-dimensional facial measurement using the 3-FSDS. Ninety-six subjects (48 subjects per each type) will be enrolled. These subjects will be randomly allocated into treatment or control groups in a 2 : 1 ratio. YGJT or placebo will be administered to each group during the 8-week treatment period. The primary outcome is total dyspepsia symptom scale, and the secondary outcomes include single dyspepsia symptom scale, proportion of responders with adequate symptom relief, visual analog scale, Nepean dyspepsia index-Korean version, functional dyspepsia-related quality of life, and spleen qi deficiency questionnaire. Discussion . This is the first randomized controlled trial to assess the efficacy of the YGJT on FD patients classified by 3-dimensional facial measurement. We will compare the treatment effect of the YGJT on FD patients classified as two types using the 3-FSDS. The results of this trial will help the FD patients improve the symptoms and quality of life effectively and provide objective evidence for prescribing the YGJT to FD patients in clinical practice. Trial Registration . This trial is registered with Clinical Research Information Service Identifier: KCT0001920 , 15 May, 2016." @default.
• W2602076204 created "2017-04-07" @default.
• W2602076204 creator A5012221143 @default.
• W2602076204 creator A5015398077 @default.
• W2602076204 creator A5023642117 @default.
• W2602076204 creator A5037444709 @default.
• W2602076204 creator A5047497320 @default.
• W2602076204 creator A5060794553 @default.
• W2602076204 creator A5080836691 @default.
• W2602076204 date "2017-01-01" @default.
• W2602076204 modified "2023-09-24" @default.
• W2602076204 title "Effects of a Herbal Medicine, Yukgunja-Tang, on Functional Dyspepsia Patients Classified by 3-Dimensional Facial Measurement: A Study Protocol for Placebo-Controlled, Double-Blind, Randomized Trial" @default.
• W2602076204 cites W1152207262 @default.
• W2602076204 cites W1545585473 @default.
• W2602076204 cites W1676494062 @default.
• W2602076204 cites W1968417656 @default.
• W2602076204 cites W1970611805 @default.
• W2602076204 cites W1976164550 @default.
• W2602076204 cites W1988293412 @default.
• W2602076204 cites W1990096734 @default.
• W2602076204 cites W1994783560 @default.
• W2602076204 cites W1995596500 @default.
• W2602076204 cites W1996237916 @default.
• W2602076204 cites W1997124843 @default.
• W2602076204 cites W1999988269 @default.
• W2602076204 cites W2003241353 @default.
• W2602076204 cites W2008036643 @default.
• W2602076204 cites W2008084630 @default.
• W2602076204 cites W2031039019 @default.
• W2602076204 cites W2034282428 @default.
• W2602076204 cites W2035804453 @default.
• W2602076204 cites W2037495061 @default.
• W2602076204 cites W2053546587 @default.
• W2602076204 cites W2061764527 @default.
• W2602076204 cites W2075781349 @default.
• W2602076204 cites W2077783666 @default.
• W2602076204 cites W2099700680 @default.
• W2602076204 cites W2101795938 @default.
• W2602076204 cites W2144799209 @default.
• W2602076204 cites W2158354121 @default.
• W2602076204 cites W2211609481 @default.
• W2602076204 cites W2312244831 @default.
• W2602076204 doi "https://doi.org/10.1155/2017/2894507" @default.
• W2602076204 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5376463" @default.
• W2602076204 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28400841" @default.
• W2602076204 hasPublicationYear "2017" @default.
• W2602076204 type Work @default.
• W2602076204 sameAs 2602076204 @default.
• W2602076204 citedByCount "5" @default.
• W2602076204 countsByYear W26020762042018 @default.
• W2602076204 countsByYear W26020762042019 @default.
• W2602076204 countsByYear W26020762042021 @default.
• W2602076204 countsByYear W26020762042022 @default.
• W2602076204 crossrefType "journal-article" @default.
• W2602076204 hasAuthorship W2602076204A5012221143 @default.
• W2602076204 hasAuthorship W2602076204A5015398077 @default.
• W2602076204 hasAuthorship W2602076204A5023642117 @default.
• W2602076204 hasAuthorship W2602076204A5037444709 @default.
• W2602076204 hasAuthorship W2602076204A5047497320 @default.
• W2602076204 hasAuthorship W2602076204A5060794553 @default.
• W2602076204 hasAuthorship W2602076204A5080836691 @default.
• W2602076204 hasBestOaLocation W26020762041 @default.
• W2602076204 hasConcept C126322002 @default.
• W2602076204 hasConcept C14184104 @default.
• W2602076204 hasConcept C142724271 @default.
• W2602076204 hasConcept C159110408 @default.
• W2602076204 hasConcept C168563851 @default.
• W2602076204 hasConcept C1862650 @default.
• W2602076204 hasConcept C188947578 @default.
• W2602076204 hasConcept C204787440 @default.
• W2602076204 hasConcept C27081682 @default.
• W2602076204 hasConcept C2779951463 @default.
• W2602076204 hasConcept C2991744798 @default.
• W2602076204 hasConcept C535046627 @default.
• W2602076204 hasConcept C71924100 @default.
• W2602076204 hasConceptScore W2602076204C126322002 @default.
• W2602076204 hasConceptScore W2602076204C14184104 @default.
• W2602076204 hasConceptScore W2602076204C142724271 @default.
• W2602076204 hasConceptScore W2602076204C159110408 @default.
• W2602076204 hasConceptScore W2602076204C168563851 @default.
• W2602076204 hasConceptScore W2602076204C1862650 @default.
• W2602076204 hasConceptScore W2602076204C188947578 @default.
• W2602076204 hasConceptScore W2602076204C204787440 @default.
• W2602076204 hasConceptScore W2602076204C27081682 @default.
• W2602076204 hasConceptScore W2602076204C2779951463 @default.
• W2602076204 hasConceptScore W2602076204C2991744798 @default.
• W2602076204 hasConceptScore W2602076204C535046627 @default.
• W2602076204 hasConceptScore W2602076204C71924100 @default.
• W2602076204 hasFunder F4320322034 @default.
• W2602076204 hasLocation W26020762041 @default.
• W2602076204 hasLocation W26020762042 @default.
• W2602076204 hasLocation W26020762043 @default.
• W2602076204 hasLocation W26020762044 @default.
• W2602076204 hasOpenAccess W2602076204 @default.
• W2602076204 hasPrimaryLocation W26020762041 @default.
• W2602076204 hasRelatedWork W1541942681 @default.
• W2602076204 hasRelatedWork W1972996206 @default.
• W2602076204 hasRelatedWork W2028699442 @default.
• W2602076204 hasRelatedWork W2033474416 @default.
• W2602076204 hasRelatedWork W2038307047 @default.

• next